Merck swings to loss as it books charge on $10.8 billion acquisition of Prometheus Biosciences
August 01, 2023 at 11:15 AM EDT
Merck's earnings were also hit by lower sales of its COVID antiviral Lagevrio.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.